Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
GT Biopharma, Inc. (GTBP) had Free Cash Flow per Share of $-58.56 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-34.45M |
|
-- |
|
-- |
|
$12.42M |
|
$-12.42M |
|
$-15.93M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-28.35M |
|
$-12.42M |
|
$-12.42M |
|
0.22M |
|
0.22M |
|
$-167.00 |
|
$-167.00 |
|
| Balance Sheet Financials | |
$8.11M |
|
-- |
|
-- |
|
$8.11M |
|
$2.32M |
|
-- |
|
-- |
|
$2.32M |
|
$5.79M |
|
$5.79M |
|
$5.79M |
|
1.02M |
|
| Cash Flow Statement Financials | |
$-12.91M |
|
-- |
|
$15.78M |
|
$4.04M |
|
$6.91M |
|
$2.86M |
|
$0.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-490.04% |
|
-489.96% |
|
-349.79% |
|
-489.96% |
|
$5.67 |
|
|
Free Cash Flow per Share |
$-58.56 |
$-58.56 |
|